Hangzhou, Zhejiang, China | Fund Name | Location |
| Ajayi Solutions | - |
| BMC | China, Shanghai |
| Chungdahm Learning | Seoul, Seoul-t'ukpyolsi, South Korea |
| comScore | Reston, United States, Virginia |
| Continuum Group | Newtown Square, Pennsylvania, United States |
| EPIC Private Equity | England, London, United Kingdom |
| Euroventures | Budapest, Hungary |
| Galena Asset Management | England, London, United Kingdom |
| MARCOL Health | England, London, United Kingdom |
| NexStreaming | Seoul, Seoul-t'ukpyolsi, South Korea |
| PA Group | England, London, United Kingdom |
| Starboard Capital Partners | Connecticut, Southport, United States |
| TechnoStart | Germany, Ludwigsburg, Mecklenburg-Vorpommern |
| TF1 Group | Boulogne, France, Nord-Pas-de-Calais |
| UHT Investments | Dubai, United Arab Emirates |
| Union Bank of Nigeria | Lagos, Lagos, Nigeria |
| Zinnov | California, Santa Clara, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
GloriousMed Technology | $15M | 08 Nov 2021 | Shangcheng District, Zhejiang, China | ||
| $4M | 20 Sep 2018 | China, Beijing | |||
WeGene | $3M | 29 Jan 2018 | Futian District, Guangdong Province | ||
GONGHUI | 21 Nov 2017 | Xiaoshan, Zhejiang, China | |||
UCHOICE | $1M | 10 May 2017 | China, Zhejiang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
GloriousMed Technology | $15M | 08 Nov 2021 | Shangcheng District, Zhejiang, China | ||
| $4M | 20 Sep 2018 | China, Beijing | |||
WeGene | $3M | 29 Jan 2018 | Futian District, Guangdong Province | ||
GONGHUI | 21 Nov 2017 | Xiaoshan, Zhejiang, China | |||
UCHOICE | $1M | 10 May 2017 | China, Zhejiang |
